Shirong Li, PhD
New York, NY
Columbia University Medical Center
I’m a Research Scientist at Columbia University Multiple Myeloma Program. I have over 20 years of research experience, especially with profound expertise in pharmaceutical biochemistry and drug development in multiple myeloma. I received my Ph.D. degree in Pharmacology and Chemistry of Peptides in 2005. After that, I did my postdoctoral training at the University of Pittsburgh Cancer Institute and have focused on multiple myeloma drug development since then. My current research aims to identify the druggable targets and develop therapeutic approaches for relapsed/refractory multiple myeloma-carrying RAS mutation. My work has been awarded by the International Myeloma Foundation Brian D. Novis Research Grant, the International Myeloma Society, and the Paula and Rodger Riney Foundation Translational Research Award. My research has also resulted in over 18 peer-reviewed articles in top journals such as JCI, Blood, and Leukemia.